摘要
目的为提高我国医药产业技术水平和研发能力提供参考。方法分析和探讨跨国制药企业在华研发投资现状及加大在华研发投资的动因和影响,并提出我国应对这一国际经济形势的对策和建议。结果与结论在跨国制药企业加大在华研发投资的背景下,我国应该趋利避害,在坚持自主创新的同时,加强国际合作,从而促进我国医药产业的发展。
OBJECTIVE:To provide references for how to enhance industrial technical level and research&development ability.METHODS:The status quo of the research&development and the investment of the multinational pharmaceutical enterprises in China,and the motive and impact of their increased investment in China were studied and analyzed.Some countermeasures and recommendations in coping with the international economical situation were presented.RESULTS&CONCLUSION:Under the situation of increasing investment on research&development in china by multinational pharma-ceutical enterprises,we should take advantage of the positive effects and avoid the negative effects,insist on independence and innovation meanwhile enhance international cooperation so as to promote the development of Chinese pharmaceutical indus-tries.
出处
《中国药房》
CAS
CSCD
北大核心
2005年第9期653-655,共3页
China Pharmacy
关键词
跨国制药企业
研发
投资
Multinational pharmaceutical enterprises
Research & development
Investment
